Recent progress in the development of anti-malarial quinolones
View/ Open
Date
2014Author
Beteck, Richard M.
Smit, Frans J.
Haynes, Richard K.
N'Da, David D.
Metadata
Show full item recordAbstract
Available anti-malarial tools have over the ten-year period prior to 2012 dramatically reduced the number of fatalities
due to malaria from one million to less than six-hundred and thirty thousand. Although fewer people now die from
malaria, emerging resistance to the first-line anti-malarial drugs, namely artemisinins in combination with quinolines and
arylmethanols, necessitates the urgent development of new anti-malarial drugs to curb the disease. The quinolones are a
promising class of compounds, with some demonstrating potent in vitro activity against the malaria parasite. This review
summarizes the progress made in the development of potential anti-malarial quinolones since 2008. The efficacy of these
compounds against both asexual blood stages and other stages of the malaria parasite, the nature of putative targets,
and a comparison of these properties with anti-malarial drugs currently in clinical use, are discussed
URI
http://hdl.handle.net/10394/16290https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-339
https://doi.org/10.1186/1475-2875-13-339
Collections
- Faculty of Health Sciences [2377]